☆ 4.6 Letter

COVID-19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments

ALLERGY (2021)

Get Full Text
Add to Collection

Journal

ALLERGY
Volume 76, Issue 3, Pages 887-892

Publisher

WILEY
DOI: 10.1111/all.14532

Keywords

-

Categories

Allergy Immunology

Funding

  1. AstraZeneca
  2. Glaxo Smith Kline
  3. Novartis
  4. Sanofi Genzyme

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.